Skip to main content
FutureChem Co., Ltd. logo

FutureChem Co., Ltd. — Investor Relations & Filings

Ticker · 220100 ISIN · KR7220100002 KO Manufacturing
Open in API
Filings indexed 312 across all filing types
Latest filing 2021-06-15 Annual Report
Country KR South Korea
Listing KO 220100

About FutureChem Co., Ltd.

https://www.futurechem.co.kr/?language=…

FutureChem Co., Ltd. is a company specializing in the development and production of radiopharmaceuticals for diagnostic and therapeutic applications. The company's operations cover the manufacturing of radiopharmaceutical precursors, chemical compounds, synthesis reagents, and automated synthesis modules. Its product pipeline focuses on agents for the diagnosis and treatment of various cancers and neurological disorders, including Parkinson's disease. FutureChem supports the broader radiopharmaceutical field by providing both finished products and the essential chemical building blocks and equipment required for their synthesis. The company actively establishes global partnerships for clinical supply and commercial licensing of its technologies.

Recent filings

Filing Released Lang Actions
[기재정정]사업보고서 (2020.12)
Annual Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a previously filed 'Business Report' (사업보고서), which is the Korean equivalent of a 10-K. It contains detailed sections on business operations, research and development activities, intellectual property, and organizational structure. Since it is a comprehensive annual filing (even if it is a correction to one), it falls under the 10-K category. FY 2020
2021-06-15 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, purpose, and method (NDR, conference call) of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it is under 5,000 characters, it falls under the category of a regulatory announcement regarding company activities.
2021-06-03 Korean
투자판단관련주요경영사항(전립선암 진단용 방사성의약품으로 개발중인 [F-18]Florastamin (프로젝트명: FC303)의 유럽 임상 3상 승인 - 유럽 오스트리아 보건식품안전청 (AGES))
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korean company FutureChem regarding the approval of a Phase 3 clinical trial for their prostate cancer diagnostic agent, [F-18]Florastamin, by the Austrian Agency for Health and Food Safety (AGES). This is a standard 'Major Management Matter' disclosure (투자판단 관련 주요경영사항) required by the Korea Exchange (KRX). Since it does not fit into specific categories like M&A, dividends, or director dealings, and is a formal regulatory disclosure of a material event, it is classified as a Regulatory Filing (RNS).
2021-05-28 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'FutureChem' covering the period from January 1, 2021, to March 31, 2021. It contains detailed corporate information, financial data, management discussion, and governance details, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-07 Korean
[기재정정]사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the company 'FutureChem' (퓨쳐켐). It contains detailed financial data, information on convertible bonds, share structure, dividend indicators, and a comprehensive 'Business Overview' (Section II) detailing industry status, market outlook, and technical terminology. This is a comprehensive annual financial filing, which corresponds to the 10-K category in the provided schema. FY 2020
2021-04-13 Korean
기타경영사항(특허권취득)(자율공시)(전립선암 진단을 위한 18F-표지된 화합물 및 그의 용도)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) by FutureChem regarding the acquisition of a patent for a prostate cancer diagnostic compound. It details the patent name, content, and utilization plan. Since it does not fit into specific categories like financial reports, dividends, or management changes, and is a standard regulatory disclosure of corporate activity, it falls under the 'Regulatory Filings' category.
2021-04-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.